A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

This study has been terminated.

( Trial was terminated to allow sponsors to evaluate the future development of the drug program )

Study NCT01016054 Information provided by Astellas Pharma Inc

First Received: November 16, 2009 Last Updated: August 30, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2010
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)